156 related articles for article (PubMed ID: 28755478)
1. Characteristics of people with high visit-to-visit glycaemic variability in Type 2 diabetes.
Noyes JD; Soto-Pedre E; Donnelly LA; Pearson ER
Diabet Med; 2018 Feb; 35(2):262-269. PubMed ID: 28755478
[TBL] [Abstract][Full Text] [Related]
2. Mean HbA
Forbes A; Murrells T; Mulnier H; Sinclair AJ
Lancet Diabetes Endocrinol; 2018 Jun; 6(6):476-486. PubMed ID: 29674135
[TBL] [Abstract][Full Text] [Related]
3. Visit-to-visit HbA1c variability is inversely related to baroreflex sensitivity independently of HbA1c value in type 2 diabetes.
Matsutani D; Sakamoto M; Minato S; Kayama Y; Takeda N; Horiuchi R; Utsunomiya K
Cardiovasc Diabetol; 2018 Jul; 17(1):100. PubMed ID: 29991356
[TBL] [Abstract][Full Text] [Related]
4. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
[TBL] [Abstract][Full Text] [Related]
5. Visit-to-visit HbA
Yang CD; Shen Y; Lu L; Yang ZK; Hu J; Zhang RY; Shen WF; Ding FH; Wang XQ
Cardiovasc Diabetol; 2020 Sep; 19(1):133. PubMed ID: 32887588
[TBL] [Abstract][Full Text] [Related]
6. Living alone is associated with visit-to-visit HbA1c variability in men but not in women in people with type 2 diabetes: KAMOGAWA-DM cohort study.
Sakai R; Hashimoto Y; Hamaguchi M; Ushigome E; Okamura T; Majima S; Asano M; Yamazaki M; Fukui M
Endocr J; 2020 Apr; 67(4):419-426. PubMed ID: 31932536
[TBL] [Abstract][Full Text] [Related]
7. Distinct trajectories of HbA
Rathmann W; Schwandt A; Hermann JM; Kuss O; Roden M; Laubner K; Best F; Ebner S; Plaumann M; Holl RW;
Diabet Med; 2019 Nov; 36(11):1468-1477. PubMed ID: 31392761
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of Long-term HbA
Sheng CS; Tian J; Miao Y; Cheng Y; Yang Y; Reaven PD; Bloomgarden ZT; Ning G
Diabetes Care; 2020 Jun; 43(6):1185-1190. PubMed ID: 32229597
[TBL] [Abstract][Full Text] [Related]
9. Rates of glycaemic deterioration in a real-world population with type 2 diabetes.
Donnelly LA; Zhou K; Doney ASF; Jennison C; Franks PW; Pearson ER
Diabetologia; 2018 Mar; 61(3):607-615. PubMed ID: 29260253
[TBL] [Abstract][Full Text] [Related]
10. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
Yang CY; Su PF; Hung JY; Ou HT; Kuo S
Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
[TBL] [Abstract][Full Text] [Related]
11. Visit-to-visit variability of glycemia and vascular complications: the Hoorn Diabetes Care System cohort.
Slieker RC; van der Heijden AAWH; Nijpels G; Elders PJM; 't Hart LM; Beulens JWJ
Cardiovasc Diabetol; 2019 Dec; 18(1):170. PubMed ID: 31830993
[TBL] [Abstract][Full Text] [Related]
12. Visit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study.
Chiu HT; Li TC; Li CI; Liu CS; Lin WY; Lin CC
PLoS One; 2017; 12(5):e0177184. PubMed ID: 28489885
[TBL] [Abstract][Full Text] [Related]
13. Predictive ability of visit-to-visit variability in HbA1c and systolic blood pressure for the development of microalbuminuria and retinopathy in people with type 2 diabetes.
Takao T; Suka M; Yanagisawa H; Matsuyama Y; Iwamoto Y
Diabetes Res Clin Pract; 2017 Jun; 128():15-23. PubMed ID: 28432895
[TBL] [Abstract][Full Text] [Related]
14. Excessive visit-to-visit glycemic variability independently deteriorates the progression of endothelial and renal dysfunction in patients with type 2 diabetes mellitus.
Wei F; Sun X; Zhao Y; Zhang H; Diao Y; Liu Z
BMC Nephrol; 2016 Jul; 17(1):67. PubMed ID: 27386849
[TBL] [Abstract][Full Text] [Related]
15. Visit-to-visit HbA1c variability is associated with aortic stiffness progression in participants with type 2 diabetes.
Fang Q; Shi J; Zhang J; Peng Y; Liu C; Wei X; Hu Z; Sun L; Hong J; Gu W; Wang W; Zhang Y
Cardiovasc Diabetol; 2023 Jul; 22(1):167. PubMed ID: 37415203
[TBL] [Abstract][Full Text] [Related]
16. Impact of insulin initiation on glycaemic variability and glucose profiles in a primary healthcare Type 2 diabetes cohort: analysis of continuous glucose monitoring data from the INITIATION study.
Manski-Nankervis J; Yates CJ; Blackberry I; Furler J; Ginnivan L; Cohen N; Jenkins A; Vasanthakumar S; Gorelik A; Young D; Best J; O'Neal D
Diabet Med; 2016 Jun; 33(6):803-11. PubMed ID: 26435033
[TBL] [Abstract][Full Text] [Related]
17. Establishing an evidence base for frequency of monitoring glycated haemoglobin levels in patients with Type 2 diabetes: projections of effectiveness from a regression model.
Oke JL; Stevens RJ; Gaitskell K; Farmer AJ
Diabet Med; 2012 Feb; 29(2):266-71. PubMed ID: 21838767
[TBL] [Abstract][Full Text] [Related]
18. Early and ongoing stable glycaemic control is associated with a reduction in major adverse cardiovascular events in people with type 2 diabetes: A primary care cohort study.
Whyte MB; Joy M; Hinton W; McGovern A; Hoang U; van Vlymen J; Ferreira F; Mount J; Munro N; de Lusignan S
Diabetes Obes Metab; 2022 Jul; 24(7):1310-1318. PubMed ID: 35373891
[TBL] [Abstract][Full Text] [Related]
19. Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA
Young TK; Li JW; Kang A; Heerspink HJL; Hockham C; Arnott C; Neuen BL; Zoungas S; Mahaffey KW; Perkovic V; de Zeeuw D; Fulcher G; Neal B; Jardine M
Diabetologia; 2021 Nov; 64(11):2402-2414. PubMed ID: 34448033
[TBL] [Abstract][Full Text] [Related]
20. Visit-to-Visit Variability of Hemoglobin A
Ghouse J; Skov MW; Kanters JK; Lind B; Isaksen JL; Blanche P; Haunsø S; Køber L; Svendsen JH; Olesen MS; Holst AG; Gerds TA; Nielsen JB
Diabetes Care; 2019 Jan; 42(1):134-141. PubMed ID: 30352898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
